Salient Capital Advisors’s Patterson-UTI PTEN Stock Holding History

Salient Capital Advisors’s Portfolio PTEN Stock Details PTEN Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2019 Q3	–	Sell	-74,930	Closed	-$862K	–	81
2019 Q2	$862K	Buy	+74,930	New	+$964K	0.02%	67
2015 Q1	–	Sell	-11,000	Closed	-$182K	–	264
2014 Q4	$182K	Hold	11,000	–	–	﹤0.01%	231
2014 Q3	$358K	Sell	11,000 -3,500	-24%	-$119K	0.01%	193
2014 Q2	$507K	Sell	14,500 -3,000	-17%	-$98.5K	0.01%	176
2014 Q1	$554K	Hold	17,500	–	–	0.02%	172
2013 Q4	$443K	Hold	17,500	–	–	0.01%	158
2013 Q3	$374K	Hold	17,500	–	–	0.02%	135
2013 Q2	$339K	Buy	+17,500	New	+$382K	0.02%	138

Other funds holding PTEN

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return

Massachusetts Financial Services Boston, Massachusetts $298B AUM 21.96% 1-Year Est. Return

Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

Wells Fargo San Francisco, California $530B AUM 22.01% 1-Year Est. Return

Macquarie Group Sydney, NSW 2000, Australia $16.8B AUM 27.39% 1-Year Est. Return

AllianceBernstein Nashville, Tennessee $309B AUM 23.92% 1-Year Est. Return

Fuller & Thaler Asset Management San Mateo, California $29.7B AUM 43.33% 1-Year Est. Return

Salient Capital Advisors's PTEN Position: Q3 2019 in Review

Salient Capital Advisors sold out of Patterson-UTI (PTEN) in Q3 2019, closing a stake of 74,930 shares — an estimated $862K sold.

Salient Capital Advisors first reported a position in PTEN in Q2 2013 and held it in 8 quarters. The position peaked at $862K in Q2 2019. 268 funds tracked by Wall St. Rank hold PTEN as of Q3 2019.

Salient Capital Advisors reported no remaining Patterson-UTI position as of Q3 2019 after selling out during the quarter.
Salient Capital Advisors sold 74,930 Patterson-UTI shares in Q3 2019, an estimated $862K.
Salient Capital Advisors first reported a position in Patterson-UTI in Q2 2013 and held it in 8 quarters.
Salient Capital Advisors's Patterson-UTI position peaked at $862K in Q2 2019.
268 funds tracked by Wall St. Rank held Patterson-UTI as of Q3 2019.

Based on Salient Capital Advisors's 13F filing for Q3 2019, filed 13 Nov 2019.